retatrutide weight loss clinical trials results Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Retatrutide, Eli Lilly's next generation

Slower, more gradual weight loss also helps preserve a higher percentage of lean mass

Marsha Novick: Mild nausea, constipation, diarrhea, fatigue, and low appetite are fairly common with GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound), especially in the first few days after an injection or after a dose increase

Start with the visible problem you're trying to solve: stubborn body condition, low play interest, or a routine that's hard to keep consistent

Its a simple way to nourish your body when your appetite is very low, and also works great as a base for soups and stews

Although he also explains that, at times, results can be affected by a few lesser-known factors